FDA approved drug Bazedoxifene as a novel inhibitor of IL 6 and IL 11/GP130 signaling for osteosarcoma therapy

被引：1
|
作者：
Wu, Xiaojuan
Xiao, Hui
Li, Chenglong
Lin, Jiayuh
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
186
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FDA-approved drug bazedoxifene as a novel inhibitor of IL-6 and IL-11/GP130 signaling for osteosarcoma therapy
    Wu, Xiaojuan
    Lin, Jiayuh
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway
    Wu, Xiaojuan
    Cao, Yang
    Xiao, Hui
    Feng, Jiexiong
    Lin, Jiayuh
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (01) : 8 - 14
  • [3] Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
    Xiao, Hui
    Bid, Hemant Kumar
    Chen, Xiang
    Wu, Xiaojuan
    Wei, Jia
    Bian, Yang
    Zhao, Chengguang
    Li, Huameng
    Li, Chenglong
    Lin, Jiayuh
    PLOS ONE, 2017, 12 (07):
  • [4] Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
    Wu, Xiaojuan
    Cao, Yang
    Xiao, Hui
    Li, Chenglong
    Lin, Jiayuh
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2609 - 2619
  • [5] Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
    Jia Wei
    Ling Ma
    Yi-Hui Lai
    Ruijie Zhang
    Huameng Li
    Chenglong Li
    Jiayuh Lin
    Journal of Experimental & Clinical Cancer Research, 38
  • [6] Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
    Wei, Jia
    Ma, Ling
    Lai, Yi-Hui
    Zhang, Ruijie
    Li, Huameng
    Li, Chenglong
    Lin, Jiayuh
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [7] Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
    Jilai Tian
    Xiang Chen
    Shengling Fu
    Ruijie Zhang
    Li Pan
    Yang Cao
    Xiaojuan Wu
    Hui Xiao
    Huey-Jen Lin
    Hui-Wen Lo
    Ying Zhang
    Jiayuh Lin
    Breast Cancer Research and Treatment, 2019, 175 : 553 - 566
  • [8] Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
    Tian, Jilai
    Chen, Xiang
    Fu, Shengling
    Zhang, Ruijie
    Pan, Li
    Cao, Yang
    Wu, Xiaojuan
    Xiao, Hui
    Lin, Huey-Jen
    Lo, Hui-Wen
    Zhang, Ying
    Lin, Jiayuh
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (03) : 553 - 566
  • [9] Bazedoxifene as a novel strategy for treatment of pancreatic adenocarcinoma through the inhibition of IL6/GP130 signaling
    Burkhardt, C.
    Buhler, L.
    Morel, P.
    Forni, M.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 22 - 22
  • [10] Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling
    Shi, Changyou
    Bopp, Taylor
    Lo, Hui-Wen
    Tkaczuk, Katherine
    Lin, Jiayuh
    CURRENT ONCOLOGY, 2024, 31 (10) : 5737 - 5751
12345